Vancouver, British Columbia--(Newsfile Corp. - December 19, 2025) - Herbal Dispatch Inc. (CSE: HERB) (OTC Pink: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company") a leading Canadian cannabis e-commerce platform specializing in small-batch craft cannabis, today shared insights from CEO Philip Campbell regarding President Trump's landmark decision to shift cannabis from Schedule I to Schedule III under the U.S. Controlled Substances Act."This development stands as a transformative breakthrough not just f ...

LONG BEACH, Calif. and TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically-integrated cannabis companies in the U.S., applauds yesterday’s cannabis reform action from the Trump administration. “The executive order to reschedule cannabis to a Schedule III classification and the authorization of a pilot program for Medicare reimbursement of the cannabis ...

Regulatory Landscape & Policy - The executive order directs the Attorney General to expedite the process for marijuana reclassification from schedule one to schedule three, but it doesn't enact any new changes [13] - The reclassification process started in the last administration as a political issue [14] - The executive order does not legalize banking for the marijuana industry, which caused pot stocks to fall [14] - The reclassification will allow for tax breaks for the marijuana industry, which could increase advertising and promotion [15][16] Health & Societal Concerns - Today's marijuana is 10 to 30 times stronger than it once was, with some cases reaching 99% THC [4] - Increased THC levels are linked to psychosis, violence, reduction in IQ, heart failure, diabetes, and stroke [5] - Medical associations worldwide agree that marijuana consumption is not beneficial and is causing addiction [7] - 30% of medical marijuana users are addicted to marijuana [10] - Concerns exist regarding the impact of marijuana legalization on the workforce, including pilots, doctors, and bus drivers [10] Market & Investment - Investors were disappointed that the executive order didn't legalize banking, leading to a drop in pot stocks [14] - Some marijuana stocks increased due to potential tax breaks, but not as much as anticipated [15] - There is no momentum in Congress for federal legalization [26] - Some states are considering repealing marijuana sales legalization [12][26]

Core Insights - Curaleaf Holdings, Inc. has terminated its binding commitment to acquire The Cannabist Company's Virginia assets due to a competing bid that valued the assets at $130 million plus a $30 million lease liability, which was deemed to exceed the rational fair value [1] - The company expects to receive a break fee of $3.3 million upon cancellation of the original commitment [1] - Curaleaf will maintain an opportunistic and disciplined approach in its acquisition strategy moving forward [2] Company Overview - Curaleaf Holdings, Inc. is a leading international provider of consumer cannabis products, with a mission to enhance lives through the power of the plant [3] - The company is recognized for its high growth, quality, expertise, and reliability, offering a wide range of products and services across medical and adult-use markets [3] - Curaleaf operates a strong distribution network throughout Europe, Canada, and Australasia, integrating pioneering science and research with advanced cultivation, extraction, and production techniques [3]

A leveraged ETF that gives investors exposure to the American cannabis industry looks set to soar following President Donald Trump’s executive order directing the easing of federal restrictions on the psychoactive substance. The AdvisorShares MSOS Daily Leveraged ETF (NYSE:MSOX) , as the name suggests, is a leveraged fund that gives investors exposure to two times the daily total return of the AdvisorShares Pure US Cannabis ETF (NYSE:MSOS) , which is seeing a lot of activity amid this major regulatory shift ...

Group 1: Canopy Growth and MTL Acquisition - Canopy Growth's CEO Luc Mongeau emphasizes that MTL's cultivation expertise, combined with Canopy's scale, will enhance product quality, expand supply, and accelerate profitable growth [1] - Under the acquisition agreement, MTL shareholders will receive 0.32 of a common share of Canopy Growth and 14.4 cents in cash for each MTL share [1] - Canopy shares closed at $2.40 on the Toronto Stock Exchange on the day of the announcement [1] Group 2: BlackBerry Financial Performance - BlackBerry reported a third-quarter profit of US$13.7 million, a significant improvement from a loss of US$10.5 million in the same period last year [4][7] - The company's revenue for the third quarter was US$141.8 million, a slight decrease from US$143.6 million year-over-year [5][7] - The QNX segment achieved record revenue of US$68.7 million, reflecting a 10% increase from US$62.3 million a year earlier [5] Group 3: Transat A.T. Financial Performance - Transat A.T. reported a loss of $12.5 million in its fourth quarter, contrasting with a profit of $41.2 million in the same quarter last year [10][13] - Revenue for the fourth quarter totaled $771.6 million, down from $788.8 million a year ago, although revenue increased by 1.5% when excluding prior compensation related to Pratt & Whitney GTF engine issues [11] - On an adjusted basis, Transat reported a loss of 42 cents per share compared to an adjusted profit of 81 cents per share in the same quarter last year [12]

Core Points - President Donald Trump's decision to relax federal marijuana regulations has been positively received by the US cannabis industry, indicating a potential shift in federal policy towards cannabis [1] - Despite the regulatory changes, the cannabis sector continues to face significant challenges, particularly in accessing mainstream financial services and banking [1] Industry Summary - The US cannabis industry is experiencing a moment of optimism due to the relaxation of federal regulations, which may lead to increased investment and growth opportunities [1] - Access to traditional banking and financial services remains a critical issue for the cannabis sector, hindering its ability to operate on par with other industries [1]

Core Viewpoint - President Donald Trump's executive order marks a significant shift in federal cannabis policy, directing federal agencies to loosen regulations on marijuana [1] Regulatory Changes - The order instructs U.S. Attorney General Pam Bondi to expedite the rescheduling of marijuana to Schedule III under the Controlled Substances Act, aligning it with common painkillers but not fully legalizing it [2] - Marijuana's current classification as a Schedule I substance has limited research opportunities, and reclassification aims to enhance studies on safety and effectiveness, particularly for vulnerable populations [4] Access to CBD Products - The order outlines steps to improve access to hemp-derived cannabinoid products, especially cannabidiol (CBD), which currently lacks a clear regulatory pathway through the FDA [5] - It directs the White House Deputy Chief of Staff to collaborate with Congress to expand access to full-spectrum CBD products while restricting those posing health risks [6] Political Reactions - Senate Minority Leader Chuck Schumer supports the order, viewing it as a positive step, but emphasizes the need for further decriminalization and easing banking regulations for the cannabis industry [7] - Conversely, some Republican senators, including Ted Budd, criticize the order as shortsighted and potentially harmful to youth [7][8] Market Reactions - Cannabis stocks initially surged following the announcement but retreated by the close, attributed to the lack of expected cannabis banking provisions in the order [9] - Despite the retreat, major cannabis stocks have seen significant gains throughout the month in anticipation of the executive order [11]

Core Viewpoint - The issuance of an executive order by President Donald Trump to reschedule cannabis from Schedule I to Schedule III under the U.S. Controlled Substances Act is a significant development for the cannabis industry, enhancing operational economics and enabling expanded medical research [2][3]. Company Summary - LEEF Brands, Inc. is a leading multi-state operator in the cannabis industry, focusing on extraction, manufacturing, and cultivation, with operations in California and New York [6]. - The rescheduling of cannabis to Schedule III will eliminate the 280E tax burden, improving cash flow and allowing LEEF to reinvest in its workforce, facilities, and long-term growth [3]. - The company operates state-of-the-art extraction and cultivation facilities and believes that the removal of 280E will strengthen balance sheets across the sector, providing more growth capital for expansion [3][4]. Industry Summary - The rescheduling of cannabis is expected to improve access to capital across the cannabis industry, potentially attracting institutional investors and broadening the pool of available lenders [4]. - Improved regulatory clarity may lower the overall cost of capital, creating opportunities for companies to fund growth and scale operations more efficiently [4]. - LEEF is also monitoring developments related to hemp-derived cannabinoids and potential Medicare coverage for certain CBD products, with a pilot program expected as early as 2026 [4].

Core Viewpoint - U.S. President Donald Trump's decision to relax marijuana regulations may alleviate some challenges for cannabis companies, but it is unlikely to improve their access to capital from major banks [1] Group 1 - The relaxation of marijuana regulations could reduce operational burdens for cannabis companies [1] - Experts suggest that despite regulatory changes, access to capital from big banks will remain restricted for the cannabis industry [1]